Mariaelena Capone

Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 13, 2026

Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.

Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma.

Journal: Journal of translational medicine

Published: June 24, 2025

Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.

Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.

Journal: Journal for immunotherapy of cancer

Published: June 02, 2025

Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.

Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 25, 2025

ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.

ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.

Journal: International journal of molecular sciences

Published: October 02, 2024

Innate Immune Cells in Melanoma: Implications for Immunotherapy.

Innate Immune Cells in Melanoma: Implications for Immunotherapy.

Journal: International journal of molecular sciences

Published: July 12, 2024

Sex-related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma.

Sex-related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma.

Journal: The FEBS journal

Published: June 11, 2024

Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.

Identification of SLC22A17 DNA methylation hotspot as a potential biomarker in cutaneous melanoma.

Journal: Journal of translational medicine

Published: June 05, 2024

Role of the androgen receptor in melanoma aggressiveness.

Role of the androgen receptor in melanoma aggressiveness.

Journal: Cell death & disease

Published: April 22, 2024

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Journal: Nature medicine

Published: April 15, 2024

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study.

Journal: EClinicalMedicine

Published: April 04, 2024

Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.

Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients.

Journal: Cell host & microbe

Published: October 17, 2023

Showing 1-12 of 73

Last Updated: 09/26/2026